Literature DB >> 24049176

Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Stéphanie B N Serre1, Henrik B Krarup, Jens Bukh, Judith M Gottwein.   

Abstract

Alpha interferon (IFN-α) is an essential component of innate antiviral immunity and of treatment regimens for chronic hepatitis C virus (HCV) infection. Resistance to IFN might be important for HCV persistence and failure of IFN-based therapies. Evidence for HCV genetic correlates of IFN resistance is limited. Experimental studies were hampered by lack of HCV culture systems. Using genotype (strain) 1a(H77) and 3a(S52) Core-NS2 JFH1-based recombinants, we aimed at identifying viral correlates of IFN-α resistance in vitro. Long-term culture with IFN-α2b in Huh7.5 cells resulted in viral spread with acquisition of putative escape mutations in HCV structural and nonstructural proteins. Reverse genetic studies showed that primarily amino acid changes I348T in 1a(H77) E1 and F345V/V414A in 3a(S52) E1/E2 increased viral fitness. Single-cycle assays revealed that I348T and F345V/V414A enhanced viral entry and release, respectively. In assays allowing viral spread, these mutations conferred a level of IFN-α resistance exceeding the observed fitness effect. The identified mutations acted in a subtype-specific manner but were not found in genotype 1a and 3a patients, who failed IFN-α therapy. Studies with HCV recombinants with different degrees of culture adaptation confirmed the correlation between viral fitness and IFN-α resistance. In conclusion, in vitro escape experiments led to identification of HCV envelope mutations resulting in increased viral fitness and conferring IFN-α resistance. While we established a close link between viral fitness and IFN-α resistance, identified mutations acted via different mechanisms and appeared to be relatively specific to the infecting virus, possibly explaining difficulties in identifying signature mutations for IFN resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24049176      PMCID: PMC3838148          DOI: 10.1128/JVI.00901-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

Review 1.  Resistance to direct antiviral agents in patients with hepatitis C virus infection.

Authors:  Christoph Sarrazin; Stefan Zeuzem
Journal:  Gastroenterology       Date:  2009-12-16       Impact factor: 22.682

2.  Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.

Authors:  François Helle; Gabrielle Vieyres; Laure Elkrief; Costin-Ioan Popescu; Czeslaw Wychowski; Véronique Descamps; Sandrine Castelain; Philippe Roingeard; Gilles Duverlie; Jean Dubuisson
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.

Authors:  Ingrid Imhof; Peter Simmonds
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

4.  Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

Authors:  Judith M Gottwein; Troels K H Scheel; Tanja B Jensen; Jacob B Lademann; Jannick C Prentoe; Maria L Knudsen; Anne M Hoegh; Jens Bukh
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 5.  Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.

Authors:  Judith M Gottwein; Jens Bukh
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

6.  Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

Authors:  Tanja B Jensen; Judith M Gottwein; Troels K H Scheel; Anne M Hoegh; Jesper Eugen-Olsen; Jens Bukh
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

7.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

Review 8.  Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

Authors:  Tarik Asselah; Emilie Estrabaud; Ivan Bieche; Martine Lapalus; Simon De Muynck; Michel Vidaud; David Saadoun; Vassili Soumelis; Patrick Marcellin
Journal:  Liver Int       Date:  2010-10       Impact factor: 5.828

9.  Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome.

Authors:  Tohru Noguchi; Tomoko Otsubaki; Izuru Ando; Naoki Ogura; Satoru Ikeda; Kunitada Shimotohno
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  14 in total

Review 1.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

2.  Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors:  Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal:  Virology       Date:  2014-05-24       Impact factor: 3.616

3.  Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.

Authors:  Jannick Prentoe; Stéphanie B N Serre; Santseharay Ramirez; Alfredo Nicosia; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 4.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

5.  Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle.

Authors:  Stéphanie B N Serre; Sanne B Jensen; Lubna Ghanem; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Henrik Krarup; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.

Authors:  Christian K Mathiesen; Jannick Prentoe; Luke W Meredith; Tanja B Jensen; Henrik Krarup; Jane A McKeating; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 7.  Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Authors:  Alexander W Tarr; Tanvi Khera; Kathrin Hueging; Julie Sheldon; Eike Steinmann; Thomas Pietschmann; Richard J P Brown
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

8.  Naturally Occurring Fc-Dependent Antibody From HIV-Seronegative Individuals Promotes HIV-Induced IFN-α Production.

Authors:  Thomas Lum; Jon A Green
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

9.  High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.

Authors:  Anne F Pihl; Anna F Offersgaard; Christian K Mathiesen; Jannick Prentoe; Ulrik Fahnøe; Henrik Krarup; Jens Bukh; Judith M Gottwein
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

Review 10.  The role of HCV proteins on treatment outcomes.

Authors:  Kattareeya Kumthip; Niwat Maneekarn
Journal:  Virol J       Date:  2015-12-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.